Sir Richard Lewis Maxwell Faull, KNZM, FRSNZ
Distinguished Professor Sir Richard Faull is Director of the Centre for Brain Research at the University of Auckland, New Zealand and Co-Director of the Centre for Research Excellence “Brain Research New Zealand.” Sir Richard Faull has an international reputation for his research studies on the human neurodegenerative diseases – Alzheimer’s, Epilepsy, Huntington’s, Parkinson’s and Motor Neuron diseases – which was made possible through his establishment of a human brain bank in partnership with the community. He is committed to helping and giving hope through research to families and people who are touched by brain disorders.
His research achievements have been recognized by several awards: he is a Fellow of the Royal Society of New Zealand; has been awarded New Zealand’s highest scientific award, the Rutherford Medal, the Liley Medal by the Health Research Council of New Zealand, and received the Supreme Award in the 2010 World Class New Zealand Awards.
Dr. Faull travel to Manila in October 2017 where he met with local neuropathologists and clinicians to offer his expertise in the the processing and analysis of postmortem brain tissue.
Awards
- Appointed Distinguished Professor at the University of Auckland
- Appointed the Sir Paul Reeves Lecturer
- Awarded the 2016 Hood Fellowship
- Appointed as a Knight Companion of the New Zealand Order of Merit (KNZM) for services to medical research in the 2017 New Year Honors.
Select Publications
Singh-Bains MK, et al. (2019) Cerebellar degeneration correlates with motor symptoms in Huntington’s disease. Annals of Neurology 85(3):396-405
Handley RR, et al. (2017) Brain urea increase is an early Huntington’s disease pathogenic event observed in a prodromal transgenic sheep model and HD cases. Proceedings of the National Academy of Science USA 26; 114(52):E11293-E11302
Schut MH, et al. (2017) Effect of post-mortem delay on N-terminal Huntington protein fragments in human control and Huntington disease brain lysates. PLoS one, 12(6). doi: 10.1371/journal.pone.0178556
Support Our Work
Your contribution helps provide care and advance research for XDP patients, especially those who cannot access sufficient medical care and social resources.